IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
What drove the drop
Anthropic announced an AI product (built on Claude/Claude Code) that can analyze and modernize COBOL applications, automating tasks IBM and peers typically perform with large consulting teams.
The tool promises to map dependencies across thousands of lines of COBOL, document workflows, and flag risks far faster and cheaper than traditional consulting projects, which directly challenges IBM’s core mainframe and COBOL‑modernization practice.
Investors fear that this kind of automation will compress IBM’s services revenue and margins over time, so they sold the stock aggressively, pushing it down around 10–11% intraday, its sharpest single‑day decline in several years.
Other pressures on the stock
The broader tech market is under pressure, with rising macro concerns and tariff headlines adding to volatility, which amplified selling in already weak consulting and legacy‑IT names.
IBM shares had recently slid on worries that AI, rather than being a pure growth driver, could also disrupt parts of IBM’s traditional services franchise, so today’s Anthropic news reinforced an existing negative narrative
Tickeron AI Perspective
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
IBM moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend. In 21 of 31 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 68%.
The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on IBM as a result. In 48 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 59%.
The Moving Average Convergence Divergence (MACD) for IBM just turned positive on October 09, 2026. Looking at past instances where IBM's MACD turned positive, the stock continued to rise in 17 of 37 cases over the following month. The odds of a continued upward trend are 46%.
The 10-day moving average for IBM crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 64%.
Following a +0.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where IBM advanced for three days, in 248 of 375 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
IBM broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for IBM entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 29 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 40 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. IBM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.934) is normal, around the industry mean (2.658). P/E Ratio (22.126) is within average values for comparable stocks, (16.591). Projected Growth (PEG Ratio) (2.087) is also within normal values, averaging (2.284). Dividend Yield (0.027) settles around the average of (0.119) among similar stocks. P/S Ratio (3.271) is also within normal values, averaging (139.965).
The Tickeron PE Growth Rating for this company is 81 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of various computer products through the use of advanced information technology
Industry InformationTechnologyServices